From GlobeNewswire: 2025-06-16 13:22:00

MediPharm Labs Corp. responds to Apollo Technology Capital Corporation’s premature claim of victory in the annual meeting of shareholders. The meeting has not yet taken place, and results will be announced after the meeting as required by law. Founded in 2015, MediPharm specializes in cannabis concentrates and pharmaceutical-grade products. In 2021, the company received a Pharmaceutical Drug Establishment License from Health Canada. The acquisition of VIVO Cannabis Inc. in 2023 expanded MediPharm’s reach to medical patients in Canada, Australia, and Germany. The company operates in compliance with all applicable laws. Investors can contact MediPharm Labs Investor Relations at +1 416.913.7425 or [email protected]. Media inquiries can be directed to John Vincic at Oakstrom Advisors.



Read more at GlobeNewswire: MediPharm Cautions Shareholders To Await Final Results of